For its fourth fiscal quarter (ending December 31), Bausch Health Cos Inc (NYSE: BHC) has reported a -327% decline in E.P.S. from $-0.11 a year ago to $0.25 in the current quarter. E.P.S. were $-0.13 for the latest four quarters through December 31 versus $-1.62 for the same period a year ago — a decline of -92%.
Recent Price Action
On 2/19/25, Bausch Health Cos Inc (NYSE: BHC) stock enjoyed a large increase of 2.4%, closing at $6.51. This advance was accompanied by normal trading volume. Relative to the market the stock has been strong over the last nine months and has risen 3.0% during the last week.
Current PriceTarget Research Rating
Bausch Health is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment